VYNE THERAPEUTICS INC.

(VYNE)
  Report
Delayed Nasdaq  -  04:00 2022-08-09 pm EDT
0.4048 USD   +0.12%
07/27VYNE THERAPEUTICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
07/19VYNE Therapeutics to Present at the B&T Cell-Mediated Autoimmune Disease Drug Development Conference
AQ
06/17VYNE Therapeutics Completes Enrollment in Trial of Atopic Dermatitis Treatment
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on VYNE THERAPEUTICS INC.
2021HC Wainwright Assumes VYNE Therapeutics at Buy with $7 Price Target
MT
2021VYNE THERAPEUTICS : Northland Adjusts VYNE Therapeutics' Price Target to $6 From $12, Keep..
MT
2021VYNE THERAPEUTICS : HC Wainwright Adjusts VYNE Therapeutics' Price Target to $11 from $14,..
MT
2021VYNE THERAPEUTICS : Barclays Adjusts Price Target for VYNE Therapeutics to $15 From $12, M..
MT
Upcoming event on VYNE THERAPEUTICS INC.